Latest Breaking News On - Molecularly targeted agents - Page 4 : comparemela.com

BioNTech to Present Clinical Data Updates for

BioNTech to Present Clinical Data Updates for
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesGenmab saFosun pharmaAmerican society of clinical oncologyRoche groupBiotheus incGenentech incAmerican societyClinical oncologyAnnual meetingChief medical officerLung cancerNon small cellBispecific antibody targetingPoster boardSolid tumors

ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST

ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
balticbusinessnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from balticbusinessnews.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesMccormick placeYuxiang maHaibo qiuHuafeng wangAscentage pharmaYifan zhaiMasa lasicaMajor nationalAmerican society of clinical oncologyDana farber cancer instituteSun yat sen university cancer centerMd anderson cancer centerZhejiang university school of medicineNational reimbursement drug list

GC Genome to Present New Clinical Data on Colorectal Cancer Detection at the ASCO Annual Meeting 2024

YONGIN, South Korea, May 7, 2024 /PRNewswire/ GC Genome Corporation, a leading diagnostics company, today announced that it will present the new clinical

San diegoUnited statesSouth koreaYelin junRachel kimSohee kimAmerican society of clinical oncologyGenece health incGc genome corporationJgc corpGc corporationClinical oncologyAnnual meetingPresentation detailsDevelopmental therapeuticsMolecularly targeted agents

ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST

ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongMccormick placeHuafeng wangPrnewswire ascentage pharmaYuxiang maHaibo qiuYifan zhaiMasa lasicaAscentage pharmaNational reimbursement drug listAmerican society of clinical oncologyChina national medical products administrationDana farber cancer instituteMd anderson cancer centerMajor national

Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting

Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Chao zengPei dongUnited statesRhui zhouYing yuanYu chenEli lillyHaibo qiuJihui haoAdimab incyteXiaohua wuInnovent biologicsZhichao jiangRui hua xuZhiguo luoYiwen chen